Trials / Completed
CompletedNCT01264822
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 108 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To survey the grade of gastric MALT lymphoma after eradication of Helicobacter pylori
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rabeprazole Sodium | The following 3 drugs are taken orally at the same time twice daily for 7 days: rabeprazole sodium 10 mg, amoxicillin hydrate 750 mg, and clarithromycin 200 mg. The dose of clarithromycin may be properly increased as needed, although the upper limit is 400 mg twice daily. If Helicobacter pylori eradication with proton pump inhibitor, amoxicillin, and clarithromycin fails, the following 3 drugs will be taken at the same time twice daily for 7 days as an alternative treatment for adults: rabeprazole sodium 10 mg, amoxicillin hydrate 750 mg, and metronidazole 250 mg. |
Timeline
- Start date
- 2011-01-13
- Primary completion
- 2016-02-29
- Completion
- 2016-11-17
- First posted
- 2010-12-22
- Last updated
- 2017-02-27
Locations
42 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01264822. Inclusion in this directory is not an endorsement.